EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential

Xiaobei Lu, Yapeng Sun, Zhaoyi Zhang, Zhigang Sun, Shaohui Wang, Erping Xu

Frontiers in Pharmacology · 09.04.2025 · 16

DOI: 10.3389/fphar.2025.1573684 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.04.2025. Verfasst von Xiaobei Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC), a chronic inflammatory bowel disease, is driven by dysregulated immune responses and persistent intestinal inflammation. Pyroptosis, a caspase/gasdermin-mediated inflammatory cell death that exacerbates mucosal damage through excessive cytokine release and epithelial barrier disruption. Although pyroptosis is considered to be a key mechanism in the pathogenesis of UC, the systematic assessment of the role of natural products in targeting the pyroptosis pathway remains a critical research gap. The purpose of this review is to investigate the regulatory effects of natural products on pyroptosis in UC and elucidate the mechanisms of action and potential therapeutic effects. Key findings highlight polyphenols (e.g., resveratrol), flavonoids (e.g., Quercetin), and terpenoids as promising agents that inhibit NLRP3 inflammasome activation, suppress gasdermin D cleavage, and restore barrier integrity, thereby reducing pro-inflammatory cytokine release in preclinical UC models. Current evidence shows enhanced efficacy and safety when these compounds are combined with standard therapies, but clinical translation requires overcoming three key barriers: limited human trial data, uncharacterized polypharmacology, and suboptimal pharmacokinetics needing formulation refinement. Future research should prioritize standardized animal-to-human translational models, mechanistic studies on synergistic pathways, and rigorous clinical validation to harness the full potential of natural products in pyroptosis-targeted UC therapies.

Schlagwörter

Stichwörter der Autor:innen

NLRP3flavonoidsnatural productspolyphenolspyroptosisulcerative colitis

Autor:innen und Institutionen

  • Traditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, China.
  • Department of Proctology, Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China.
  • Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China.

Zitieren

APA

Lu, X., Sun, Y., Zhang, Z., Sun, Z., Wang, S., & Xu, E. (2025). Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1573684

Vancouver

Lu X, Sun Y, Zhang Z, Sun Z, Wang S, Xu E. Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1573684

BibTeX
@article{Lu2025,
  author = {Lu, Xiaobei and Sun, Yapeng and Zhang, Zhaoyi and Sun, Zhigang and Wang, Shaohui and Xu, Erping},
  title = {Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1573684}
}
Kostenlos starten →